Literature DB >> 16797139

Reasons for substance use and vulnerability factors in patients with substance use disorder and anxiety or mood disorders.

Jacopo V Bizzarri1, Paola Rucci, Alfredo Sbrana, Chiara Gonnelli, Guido Jacopo Massei, Laura Ravani, Massimo Girelli, Liliana Dell'osso, Giovanni B Cassano.   

Abstract

This cross-sectional study examined the reasons for substance use and the presence of vulnerability factors such as substance sensitivity, sensation seeking, and symptoms related to the attention deficit hyperactivity disorder (ADHD) in patients with substance use disorder (SUD) and comorbid mood and anxiety disorders by using the Structured Clinical Interview for the Spectrum of Substance Use (SCI-SUBS), a novel instrument designed to explore the spectrum of substance use and its clinical correlates. Study participants included 61 patients with SUD and mood or anxiety disorder, and two comparison groups including 35 patients with SUD only and 50 controls not in treatment for mental disorders or SUD. We found that patients with co-morbid mood or anxiety disorder had significantly higher scores on the SCI-SUBS domains 'substance sensitivity' and 'self-medication' as compared to those with SUD only. Scores on 'sensation seeking' and 'ADHD' domains were similar between both groups of patients and higher than in controls. Patients with comorbid mood or anxiety disorders showed a higher sensitivity to substances and were more prone to self-medication than those with SUD only. These characteristics should be taken into account in the diagnostic assessment and in long-term treatment to decrease the risk of relapse.

Entities:  

Mesh:

Year:  2006        PMID: 16797139     DOI: 10.1016/j.addbeh.2006.04.005

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  10 in total

Review 1.  Unravelling the Link Between Prenatal Stress, Dopamine and Substance Use Disorder.

Authors:  Verónica Pastor; Marta Cristina Antonelli; María Eugenia Pallarés
Journal:  Neurotox Res       Date:  2016-10-24       Impact factor: 3.911

2.  Racial/ethnic subgroup differences in outcomes and acceptability of an Internet-delivered intervention for substance use disorders.

Authors:  Aimee N C Campbell; L Montgomery; Katherine Sanchez; M Pavlicova; M Hu; H Newville; L Weaver; E V Nunes
Journal:  J Ethn Subst Abuse       Date:  2017-04-03       Impact factor: 1.507

3.  Bipolar disorder and criminal offending: a data linkage study.

Authors:  Elizabeth Daff; Stuart D M Thomas
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-05-04       Impact factor: 4.328

4.  Affective temperaments in alcohol and opiate addictions.

Authors:  Yasser Khazaal; Marianne Gex-Fabry; Audrey Nallet; Béatrice Weber; Sophie Favre; Raphael Voide; Daniele Zullino; Jean-Michel Aubry
Journal:  Psychiatr Q       Date:  2013-12

5.  Does adolescent weight status predict problematic substance use patterns?

Authors:  H Isabella Lanza; Christine E Grella; Paul J Chung
Journal:  Am J Health Behav       Date:  2014-09

6.  Depressive Symptoms and Associated Clinical Characteristics in Outpatients Seeking Community-Based Treatment for Alcohol and Drug Problems.

Authors:  Katherine Sanchez; Robrina Walker; Aimee N C Campbell; Tracy L Greer; Mei-Chen Hu; Bruce D Grannemann; Edward V Nunes; Madhukar H Trivedi
Journal:  Subst Abus       Date:  2014-08-01       Impact factor: 3.716

7.  Adolescent obesity and future substance use: Incorporating the psychosocial context.

Authors:  H Isabella Lanza; Christine E Grella; Paul J Chung
Journal:  J Adolesc       Date:  2015-09-05

8.  Gender Differences in the Relationship between Maladaptive Behaviors and Post-Traumatic Stress Disorder. A Study on 900 L' Aquila 2009 Earthquake Survivors.

Authors:  Liliana Dell'osso; Claudia Carmassi; Paolo Stratta; Gabriele Massimetti; Kareen K Akiskal; Hagop S Akiskal; Icro Maremmani; Alessandro Rossi
Journal:  Front Psychiatry       Date:  2013-01-04       Impact factor: 4.157

Review 9.  A Narrative Literature Review of the Epidemiology, Etiology, and Treatment of Co-Occurring Panic Disorder and Opioid Use Disorder.

Authors:  Ashton E Clark; Shelby R Goodwin; Russell M Marks; Annabelle M Belcher; Emily Heinlein; Melanie E Bennett; Daniel J O Roche
Journal:  J Dual Diagn       Date:  2021-09-28

10.  Developmental psychopathology: Attention Deficit Hyperactivity Disorder (ADHD).

Authors:  Sören Schmidt; Franz Petermann
Journal:  BMC Psychiatry       Date:  2009-09-17       Impact factor: 3.630

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.